Background Published small case series suggest that inflammatory bowel disease [IBD;
Crohn's disease (CD) or ulcerative colitis (UC)] and vasculitis co-occur more frequently than …

Takayasu arteritis (TA) is a rare large vessels vasculitis. Conventional therapy consists of
glucocorticoids which may be associated with other immunosuppressive drugs. However …

Background—The goal of this work was to assess the safety and efficacy of biologics (ie,
tumor necrosis factor-α antagonists and tocilizumab) in patients with Takayasu arteritis …

Objective To assess the safety and the efficacy of TNF-α antagonists and tocilizumab in
patients with Takayasu arteritis (TAK). Methods A total of 209 patients with TAK [median age …

Anti-TNF agents are recommended for the treatment of Takayasu's patients who are unable
to taper prednisone despite treatment with a nonbiologic immunosuppressive medication …

TNF-α inhibitor (TNFi) therapies have transformed the treatment of several rheumatic
musculoskeletal diseases. However, the majority of TNFi's are immunogenic and …

Background Magnetic resonance imaging (MRI) and computed tomography (CT)
angiography have now largely replaced interventional angiography in the diagnoses and …

Background Takayasu arteritis (TAK) is a large vessel vasculitis that rarely affects children.
Data on childhood TAK are scarce. The aim of this study was to analyze the presenting …

Introduction. The mainstay in the treatment of the large-vessel vasculitides giant cell arteritis
(GCA) and Takayasu arteritis (TA) are glucocorticosteroids (GC) for induction of remission as …

Takayasu arteritis (TA) is a granulomatous vasculitis of large vessels with unknown
aetiopathogenesis. An association between TA and tuberculosis (TB) has been suggested …